New Key Statistics Module, Z-Score and F-Score
NAS:POAI Key Ratios
| Market Cap $ M | 5.17 |
| Enterprise Value $ M | 2.91 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.26 |
| Price/Sales | 2.71 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -3.65 |
| Beneish M-Score | -2.51 |
| 10-y EBITDA Growth Rate % | 58.50 |
| 5-y EBITDA Growth Rate % | 56.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.20 |
| EV-to-EBITDA | -0.21 |
| PEG | -- |
| Shares Outstanding M | 4.10 |
| Net Margin (%) | -754.08 |
| Operating Margin % | -749.64 |
| Pre-tax Margin (%) | -754.08 |
| Quick Ratio | 1.35 |
| Current Ratio | 1.45 |
| ROA % (ttm) | -82.83 |
| ROE % (ttm) | -129.11 |
| ROIC % (ttm) | -257.45 |
| Dividend Yield % | -- |
| Altman Z-Score | -26.39 |
POAI Number of Guru Trades
POAI Volume of Guru Trades
Gurus Latest Trades with NAS:POAI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:POAI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Predictive Oncology Inc Insider Transactions
No Available Data
News about NAS:POAI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers